Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$7.89 - $10.64 $63,909 - $86,184
8,100 Added 8.04%
108,900 $1.13 Million
Q1 2023

May 10, 2023

SELL
$7.07 - $17.95 $83,426 - $211,810
-11,800 Reduced 10.48%
100,800 $815,000
Q4 2022

Feb 08, 2023

BUY
$14.33 - $18.37 $30,093 - $38,577
2,100 Added 1.9%
112,600 $1.77 Million
Q3 2022

Nov 09, 2022

BUY
$13.07 - $18.22 $124,165 - $173,090
9,500 Added 9.41%
110,500 $1.74 Million
Q2 2022

Aug 09, 2022

SELL
$10.16 - $17.08 $76,200 - $128,099
-7,500 Reduced 6.91%
101,000 $1.41 Million
Q1 2022

May 09, 2022

BUY
$9.74 - $17.92 $73,050 - $134,400
7,500 Added 7.43%
108,500 $1.87 Million
Q4 2021

Feb 08, 2022

BUY
$12.27 - $18.49 $46,626 - $70,262
3,800 Added 3.91%
101,000 $1.47 Million
Q2 2021

Aug 06, 2021

BUY
$17.08 - $29.6 $1.66 Million - $2.88 Million
97,200 New
97,200 $1.71 Million
Q2 2019

Aug 02, 2019

SELL
$2.13 - $7.06 $135,042 - $447,604
-63,400 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$5.63 - $7.84 $30,402 - $42,336
5,400 Added 9.31%
63,400 $380,000
Q4 2018

Feb 13, 2019

BUY
$6.3 - $15.4 $101,430 - $247,940
16,100 Added 38.42%
58,000 $429,000
Q1 2018

May 04, 2018

BUY
$17.08 - $25.64 $44,407 - $66,664
2,600 Added 6.62%
41,900 $734,000
Q3 2017

Nov 03, 2017

BUY
$23.02 - $28.8 $904,686 - $1.13 Million
39,300
39,300 $1.01 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.